Cardiac‐specific downregulation of Decr1 improved T2D‐induced cardiac dysfunction, as evidenced by significant increases in left ventricular ejection fraction (EF), and fractional shortening (FS) (Figure S3b, Table S5). The gene discussed is DECR1; the disease is type 2 diabetes mellitus.